L-NAPNA is a nitric oxide synthase ( NOS ) inhibitor with an IC 50 of 1.4 μM. L-NAPNA exhibits analgesic effects by inhibiting formalin-induced paw licking behavior in mice ( ED 50 of 57.2 mg/kg) and suppressing acetic acid-induced abdominal writhing in mice ( ED 50 of 25 mg/kg). L-NAPNA can be used in research related to central nervous system diseases.
Products | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Signaling Pathways > Immunology/Inflammation | Products > Research Areas > Neurological Disease | Products > Signaling Pathways > NO Synthase
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.